R. P. Warrell

Acute promyelocytic leukemia cell line AP-1060 established as a cytokine-dependent culture from a patient clinically resistant to all-trans retinoic acid and arsenic trioxide

A. Zelent, E. Paietta, R. Gallagher, 2004, Leukemia.

Prognostic significance of minimal residual disease detection and PML/RAR-alpha isoform type: long-term follow-up in acute promyelocytic leukemia.

D. Scheinberg, R. Warrell, W. Miller, 2001, Blood.

SAT0539 Novel Bifunctional Inhibitors of Xanthine Oxidase and URAT1 Induce Profound Hypouricemia in Human Subjects

C. Cheeseman, J. Piwinski, A. Klukovits, 2014 .

Retinoic acid (RA) and As2O3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RARalpha and PLZF-RARalpha oncoproteins.

P. Pandolfi, Z. G. Wang, R. Warrell, 2000, Proceedings of the National Academy of Sciences of the United States of America.

Acute promyelocytic leukemia.

R. Warrell, Zhen-yi Wang, H. de Thé, 1993, The New England journal of medicine.

Pilot study of combination transcriptional modulation therapy with sodium phenylbutyrate and 5-azacytidine in patients with acute myeloid leukemia or myelodysplastic syndrome

P. Pandolfi, S. Soignet, P. Maslak, 2006, Leukemia.